Mary K Hayden, Kimberly E Hanson, Janet A Englund, Mark J Lee, Mark Loeb, Francesca Lee, Daniel J Morgan, Robin Patel, Ibrahim K El Mikati, Shahad Iqneibi, Farouk Alabed, Justin Z Amarin, Razan Mansour, Payal Patel, Yngve Falck-Ytter, Rebecca L Morgan, M Hassan Murad, Shahnaz Sultan, Adarsh Bhimraj, Reem A Mustafa
Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19) and for identifying asymptomatic carriage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The number of available SARS-CoV-2 nucleic acid detection tests continues to increase as does the COVID-19 diagnostic literature. Thus, the Infectious Diseases Society of America (IDSA) developed an evidence-based diagnostic guideline to assist clinicians, clinical laboratorians, patients, and policymakers in decisions related to the optimal use of SARS-CoV-2 nucleic acid amplification tests...
December 19, 2023: Clinical Infectious Diseases